Several other equities research analysts have also issued reports on REPL. BMO Capital Markets boosted their price target on shares of Replimune Group from $18.00 to $27.00 and gave the company an ...

Replimune Group, Inc. (NASDAQ:REPL – Free Report) – Research analysts at Leerink Partnrs lowered their FY2025 earnings estimates for Replimune Group in a report released on Wednesday ...

Wedbush raised the firm’s price target on Replimune (REPL) to $19 from $16 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source for real-time ...

The report is limited to equity securities, including common and equivalents, convertible preferred and convertible bonds. The report does not include fixed income, real estate, or cash equivalents.

Barclays analyst Peter Lawson maintained a Buy rating on Replimune Group (REPL – Research Report) today and set a price target of $17.00. The company’s shares closed yesterday at $13.79.

Shares of Replimune Group (REPL) surged 29.19% following news the ... New Oriental Education (EDU) shares tumble to 25.06% on earnings miss. Revenue was up 19.6% year-over-year to $1.04 billion ...